[This review was originally posted at the Nieman Journalism Lab Diflucan No Rx, on July 20, 2012.]
Yahoo's surprising hire: Yahoo's struggles over the past several years have been well documented, but the company made a big splash this week with its choice of a new CEO to try to lead its turnaround — top Google executive Marissa Mayer. Some observers, such as TechCrunch founder Michael Arrington and Wired's Steven Levy, saw the hiring of Mayer, who spent much of her time at Google heading up its search and location division, as an ideal fit for Yahoo. Others, like GigaOM's Mathew Ingram, Diflucan images, entrepreneur Mike Walrath, and Forrester's Shar VanBoskirk, said that as a technologist, Mayer makes a poor fit with a company whose future should lie in improving its media products, rather than its technological innovation.
The Guardian's Charles Arthur argued that by hiring Mayer, Order Diflucan from United States pharmacy, Yahoo is indeed making a clear statement that it's a technology company more than anything. Staci Kramer of paidContent made a similar point, saying the board opted to focus on improving its products over its media offerings — and it's harder to find good leaders in the former than the latter.
But as PandoDaily's Sarah Lacy noted, Yahoo has a long, ugly history with its headline-grabbing CEO hires and a lot of issues to address, Diflucan No Rx. Kara Swisher of All Things D posed several of those issues as questions to Mayer, wondering how she'll attract the top talent to engineer a turnaround while also making necessary cuts. Here at the Lab, Ken Doctor said the key question is what Mayer can bring to Yahoo that makes the company truly distinctive, and predicted that specialty will revolve around mobile media, Diflucan wiki.
Mayer told The New York Times she plans to focus on improving Yahoo's user experience, which, of course, could mean just about anything. The Atlantic's Megan Garber pointed out that the Internet's top priority for Yahoo seems to be getting its photo-sharing site Flickr fixed, and Julieanne Smolinski of XOJane urged Mayer to keep Yahoo "the dive bar of the Internet." Danny Sullivan of Search Engine Land looked at the implications for search, Diflucan no prescription, predicting that Mayer will actually start to sunset Yahoo's search effort.
The mixed legacy of Digg Diflucan No Rx, : Digg, the social-news network that had been considered at one point the vanguard of the movement into social media, reached what will probably be seen as its nadir last week when it was sold for a reported $500,000 to the tech firm Betaworks. (Including the prior sales of some of its assets, the total was probably actually at least $16 million.) The sale marked the end of a long downfall for Digg, which Megan Garber of The Atlantic chronicled by the numbers.
Betaworks plans to incorporate Digg into its personalized news aggregator, News.me, in an effort to reinvent both products, according to Mathew Ingram of GigaOM, Diflucan used for. Betaworks CEO John Borthwick said his company plans to revert Digg to startup mode. If Betaworks succeeds in reinvigorating Digg, PandoDaily's Erin Griffith noted that it could become the web's first full turnaround story.
The main questions that emerged in the wake of the deal had to do with why Digg fell so far, and what other organizations could learn from its demise, Diflucan No Rx. Digg's founder, Kevin Rose, argued that Digg failed because social media "grew up" as platforms like Facebook and Twitter did what Digg attempted to do, Generic Diflucan, only better. Paul Tassi of Forbes disputed that idea, arguing that Reddit is filling the exact niche Digg had hoped to fill.
Both Patricio Robles of Econsultancy and Jeff Bercovici of Forbes put together lists of lessons from Digg's collapse, with the importance of listening to your product's users emerging as a theme. That point was put most forcefully by Alexis Madrigal of The Atlantic, who wrote that Digg broke down because its community broke, meaning that "the technology that powered a once-massive social network is worth about $500, Diflucan duration,000. All the rest of the value derives from the people that use it."
A few writers pointed out that Digg did accomplish some important things during its run: Om Malik of GigaOM praised Digg Diflucan No Rx, as a company that "opened our eyes to the potential of the social web," and former Digg employee Aubrey Salaba of TechCrunch and former Digg devotee MG Siegler gave more personal appreciations of the site. Brian Morrissey of Digiday noted another important innovation Digg helped develop — ads that were actually a native part of the site's structure itself.
Journalism's dirty little quote approval secret: The New York Times reported this week on an alarming practice that's becoming commonplace among American campaign journalism — allowing sources to review and even change tape-recorded quoted comments. Several of the country's premier news organizations quickly responded to the exposé: Reuters and AP condemned the practice, The New York Times, Los Angeles Times, Where can i cheapest Diflucan online, and websites Buzzfeed and RealClearPolitics began reviewing their practices, and Politico's editor-in-chief expressed his concern.
The practice drew virtually universal disapproval from media observers. Perhaps the strongest condemnation came in The Guardian from Jeff Jarvis, who wrote that "When journalists give sources the opportunity to fix up what they've said, we become complicit in their spin, Diflucan No Rx. When we do so without revealing the practice, we become conspirators in a lie to the people we are supposed to serve: the public."
Others made similar points: Mother Jones' Kevin Drum said reporters are edging toward stenography, Dan Rather argued at CNN that this should prompt the public to question their trust in reporters, and Time's James Poniewozik and former newspaper editor John L. Robinson (among others) countered the objection that reporters get valuable stories through this tactic, Diflucan without prescription.
The Guardian's Ian Traynor warned American journalists with examples from Germany where requiring quote approval is standard practice. New York magazine's Joe Coscarelli said this gives live television the upper hand as "the real gladiator arena in today's YouTube-able, gaffe-centric political culture," and Carl Sessions Stepp of the American Journalism Review looked at the issue from sources' perspective, urging us to cut them a bit more slack when they do commit gaffes.
A new public editor at the Times: Marissa Mayer wasn't the only high-profile media/tech hire this week — The New York Times hired its first woman public editor Diflucan No Rx, , Margaret Sullivan, executive editor of the Buffalo News. Sullivan signed on for four years, Order Diflucan online overnight delivery no prescription, longer than any previous public editor. Poynter's Bill Mitchell and the Columbia Journalism Review's Sara Morrison talked to Sullivan about her plans for the position, which includes engaging in a more regular conversation with readers through the blog while keeping the more in-depth focus of the print column. You can also see a new Nieman Reports story of hers on the way the News handled a controversial crime story.
Sullivan told Mitchell and Michael Calderone of the Huffington Post that her experience as a woman would inform her perspective generally, but not in any specific way. Poynter's Mallary Jean Tenore argued that Sullivan's role as a woman may be more important than she's giving it credit for, and Sullivan wrote a blog post of her own what role her gender will and won't play in her public editing philosophy, Diflucan No Rx.
Sullivan also addressed the most controversial column of her predecessor, Arthur Brisbane, Diflucan dosage, telling Media Matters' Joe Strupp that she does indeed believe the Times should be a "truth vigilante." Isaac Chotner of The New Republic urged her not to follow Brisbane's example in indulging the inane complaints of readers. But tech pioneer Dave Winer, however, argued that the Times' public editor should identify more closely with the public, rather than the paper. "A good Public Editor is over-the-top critical of the news organization. He or she errs on the side of being fair to the Public and unfair to the news organization. The Public Editors the Times has hired have flipped it the other way around, Kjøpe Diflucan på nett, köpa Diflucan online, " he wrote.
A place for outsourcing in journalism?: Things just keep getting worse for local content provider Journatic in the wake of the revelation a few weeks ago that it's been using fake bylines on some pieces. Diflucan No Rx, The Chicago Tribune, which has invested in Journatic and had turned its TribLocal content over to the company, suspended its use of Journatic content after discovering some plagiarism in it. (Its newsroom is taking back over the TribLocal work.) Poynter also found more than 350 Journatic pieces for the Houston Chronicle with fake bylines, prompting internal reviews of Journatic content by both the Chronicle and its sister paper, the San Francisco Chronicle.
Meanwhile, Journatic sent an internal memo urging writers not to plagiarize or lie about their names or where they're working from. And one of Journatic's executives said he resigned because of conflicts over the company's ethical values, Diflucan brand name, though Journatic said it was about to fire him anyway. (Virtually all of those links are via Poynter's excellent coverage of the saga.)
Opinions on the dangers of semi-automated, outsourced journalism like Journatic's continued to flow in, including a discussion on the Bay Area's KQED radio and a Miami Herald column by Edward Wasserman. Others cautioned not to dismiss outsourced or content-farmed journalism out of hand: Poynter's Craig Silverman said this type of model is inevitable but needs to be done better, and GigaOM's Mathew Ingram said Journatic is just one (very flawed) way of trying to solve the problem of paying for commodity journalism, Diflucan No Rx. Spot.Us founder David Cohn outlined some lessons for journalists about the difficulties of building a content business on local data while trying to negotiate long-held journalism customs.
Reading roundup: It's been a really, Where can i buy Diflucan online, really busy week in media and tech. Here are a few of the stories that might have gotten lost in the shuffle:
— I noted last week that News Corp. is considering shutting down its daily tablet publication, The Daily. The publication launched a weekend edition Diflucan No Rx, , WKND, last weekend, and several analysts looked at why The Daily has struggled: The Next Web looked at the money, paidContent looked across some of the deeper issues involved, and Gawker's Hamilton Nolan offered a simpler rationale. Media analyst Frederic Filloux gave the most thorough explanation, calling The Daily "a sophisticated container for commodity news."
— This week's paywall notes: A report found that half of the revenue in a newspaper paywall comes in the first three months, and the Australian site Mumbrella questioned whether paywalls are changing the way reporters write. Meanwhile, Washington Post publisher Don Graham explained why his paper will never institute a paywall.
— A new study by Pew's Project for Excellence in Journalism detailed the news environment that's emerging on YouTube. The Washington Post focused on the rise of news' popularity there, and the Lab's Adrienne LaFrance offered a great analysis of what works and what doesn't for news on YouTube.
Similar posts: Lipitor Price. Flagyl For Sale. Bactrim Mg. Kjøpe Lipitor på nett, köpa Lipitor online. Zoloft pics. Canada, mexico, india.
Trackbacks from: Diflucan No Rx. Diflucan No Rx. Diflucan No Rx. Diflucan from canadian pharmacy. Diflucan no prescription. Diflucan dosage.
[This review was originally posted at the Nieman Journalism Lab Glucophage Cost, on July 13, 2012.]
Evaluating newspapers' various strategies: Several wide-ranging strategies in the newspaper industry have been making headlines lately (Newhouse's draconian cuts in New Orleans, Warren Buffett's aggressive newspaper purchases, outsourcing hyperlocal news to Journatic), and The New York Times' David Carr tied a lot of them together in a sharp column identifying the severe financial difficulties facing the newspaper industry. The piece of news he reported was the fact that pension funds at major newspaper chains like Gannett and McClatchy are underfunded by hundreds of millions of dollars. Gannett Blog's Jim Hopkins said that finding deserves some attention.
One of the most prominent responses to these financial threats has been the implementation of online paywalls, a strategy that eByline's Peter Beller reported is more common at larger papers, to the point where it now affects a third of America's daily newspaper readers, buy Glucophage online no prescription. Closely tied to that strategy is a doubling-down by publishers on "original reporting" online, which media analyst Frederic Filloux contended is a losing proposition, because aggregators' tech- and marketing-savviness are trumping the quality of traditional publishers' work in the battle for online readers. British journalist Adam Tinworth said part of the problem is that publishers are trying out and pitching new digital strategies far too often, instead of being patient enough to see one through, Glucophage Cost.
Here at the Lab, Where can i find Glucophage online, Ken Doctor responded to all the hand-wringing with a list of reasons for hope in the news industry, including the potential in digital circulation, the growth of tablets, community blogs, and customer data.
Elsewhere, where can i order Glucophage without prescription, media analyst Alan Mutter categorized three strategies for newspapers dealing with the new digital environment — keeping up the status quo as long as possible ("farming" it), accepting print's decline and extracting as much money as possible before it finally goes ("milking" it), and leveraging old media resources to aggressively invest in digital innovation ("feeding" it). He mapped a different publisher to each approach — Buffett to farming, Online buying Glucophage, Newhouse to milking, and Rupert Murdoch to feeding — and ultimately endorsed Murdoch's plan.
Peter Kirwan of The Media Briefing also praised Murdoch's efforts to turn up the pressure on his print properties to start making money through digital innovation: Some of the experiments might backfire, he said, but "whatever it takes, speeding up the pace of digital transition can only be a good thing."
Newhouse's detractors and defenders: One of those newspapers has drawn particular attention over the past month or so — the New Orleans Times-Picayune, buy Glucophage from canada, which has now undergone its drastic layoffs and plans to cut down its publishing three days a week this October. Glucophage Cost, This week, the Newhouse family, which owns the paper, rejected a request by several New Orleans bigwigs to sell the paper to an unnamed buyer whom they have reportedly lined up. One local court also moved its public notices from the TP to the weekly paper the Gambit, and the paper is also receiving rants from its reporters about its poor website.
Newhouse's moves continue to draw strong criticism from media observers, Online buy Glucophage without a prescription, including former newspaper editor John L. Robinson, who attributed the changes to the fundamental conflict between public service and profits. "Profit trumps readers every time. The owners may appreciate the public service journalism the paper may produce, but it isn’t what they value the most," he wrote. And former Baltimore Sun reporter and "The Wire" creator David Simon argued in the Gambit that what's being lost in newspapers' evisceration is the public accountability provided by beat reporting, Glucophage from mexico.
But Newhouse has its defenders, too, including Digital First CEO John Paton, who argued that while the company is handling the transition poorly, it's still making the type of difficult, digitally centered change that's necessary for the business to survive, Glucophage Cost. GigaOM's Mathew Ingram concurred. Rem Rieder of the American Journalism Review acknowledged that arduous change is necessary for newspapers, but said the clumsiness with which Newhouse has handled its moves in New Orleans has swallowed up its goodwill and set the cause of change back.
Two studies with good news for mobile news: Two studies with interesting implications for digital news were released this week, Glucophage class, one on mobile news consumption and the other an international study on digital and mobile news consumption. The first, conducted by the Reynolds Journalism Institute, found that users of large tablets (i.e. Glucophage Cost, iPads and the like, rather than Kindle Fires) were older, more likely to pay for digital news, and particularly enjoyed reading on the tablet compared with other media. Poynter's Jeff Sonderman noted that those results makes "tablet readers seem the best hope for print publishers that want to make a digital transition based on paid content."
Slate's Will Oremus echoed that idea, though he cautioned that tablets may do more to eat into evening news' audience than help the traditional publishing industry, Glucophage without a prescription. This study was the final part of a three-part study on mobile media, and Amy Gahran of the Knight Digital Media Center gave some suggestions for future mobile news research, including focusing on community news in particular.
The second study, Ordering Glucophage online, issued by Oxford's Reuters Institute, looked at digital news use in the U.S. and four European countries, with findings focusing on the rise of smartphones and tablets, as well as young people's changing news consumption habits. PaidContent's Robert Andrews highlighted the increasing willingness to pay for news among young smartphone and tablet owners, Glucophage Cost. J-prof Alfred Hermida dug into the numbers and pointed out that while the use of social media for news is up sharply, Glucophage for sale, it's driven by a small core of heavy news sharers.
Does outsourcing have a place in local news?: Last week's controversy regarding fake bylines at the hyperlocal content provider Journatic continued to generate debate this week, especially for newspaper columnists who defended the value of locally produced news (such as, say, Glucophage reviews, the news that appears in their newspaper). WNPR public radio hosted a discussion on outsourcing local news, and while former Patch editor-in-chief Brian Farnham didn't defend Journatic (he said it "gives me a cheap feeling"), he did say the overwhelming nitpicking and self-criticism coming from within journalism makes it difficult for any digital journalism initiative to survive.
Danish j-prof Rasmus Kleis Nielsen argued that with news' business model collapsing, the question isn't whether some aspects should be outsourced, cheap Glucophage no rx, but what and when. Glucophage Cost, If this episode illustrates that the article is untouchable, though, the scale of news production is going to have to decline, he said. "Cottage production works for the few, I don’t see how it will work for the many."
Reading roundup: No big stories this week, but lots of smaller ones to keep up with:
— Some continued discussion about CNN's (and others') Supreme Court reporting fiasco: The New Republic's Amy Sullivan urged journalists to stop caring about scoops, and reporters responded by defending the importance of speed in news. Sullivan replied that it's not really about speed per se, but obsession with being first with information that will become widely distributed almost immediately anyway. Poynter's Craig Silverman pulled some lessons for newsrooms from the fiasco. Buy cheap Glucophage, — Next Issue Media, a digital media joint venture among several top media companies, issued its iPad edition, which allows subscribers to read all they want of 39 magazines for a flat monthly fee — what Shawn King of The Loop and others called the Netflix model for magazines. Time's Harry McCracken said its audience will probably be limited to print magazine junkies, and GigaOM's Mathew Ingram was skeptical of the plan as a way to emulate print reading experiences, Glucophage long term.
— A group of media moguls met this week in California to talk about a variety of issues, one of which was the defeat this winter of their SOPA/PIPA anti-piracy laws. The New York Times and Forbes have more details about how that fight between media and tech is progressing, and Bloomberg broke down some of the other issues the executives would be discussing.
— The New York Observer's Kat Stoeffel reported that News Corp.'s money-losing tablet news publication, The Daily, has been placed "on watch," to be evaluated (and possibly killed) after November's election. Business Insider's Henry Blodget said The Daily has failed because it failed to carve out a niche or a distinct perspective.
— A few thought-provoking pieces that deserve a read this week: Two from the Columbia Journalism Review on making freelancing sustainable in the digital world and on the battle over the network nightly newscasts, and one here at the Lab by Jonathan Stray on getting ourselves out of like-minded "filter bubbles" in our online information consumption.
Similar posts: Lipitor Cost. Cephalexin No Rx. Buy Retin A No Prescription. Armour results. Synthroid price, coupon. Armour price, coupon.
Trackbacks from: Glucophage Cost. Glucophage Cost. Glucophage Cost. Glucophage trusted pharmacy reviews. Glucophage canada, mexico, india. After Glucophage.
[This review was originally posted at the Nieman Journalism Lab Buy Cipro No Prescription, on July 9, 2012.]
Journatic and new directions for local news: The hyperlocal news content provider Journatic got caught last week using fake bylines, prompting a discussion about the value and perils of outsourced journalism. Journatic provides hyperlocal content to a variety of publications (especially newspapers) through a network of freelancers. Those freelancers are often not in the area (or even the country) they're writing about, and as a This American Life piece revealed, some of them have also been using fake bylines. Cipro use, At Poynter, Anna Tarkov has the full story of how the Journatic sausage gets made, and Jim Romenesko got responses from Journatic's CEO and the TAL story's producer and main subject.
The Chicago Tribune just outsourced its hyperlocal TribLocal sections to Journatic, and it began investigating Journatic's work for fake bylines. The Chicago Sun-Times, Houston Chronicle, and San Francisco Chronicle also reported fake bylines on Journatic stories in their papers, and the Sun-Times and the newspaper chain GateHouse ended their contracts with Journatic, though GigaOM's Mathew Ingram reported that those contracts expired before the fake-byline story came out, Buy Cipro No Prescription. Journatic's CEO sent a memo rallying the troops and declaring that its aliases would be discontinued, Cipro from canadian pharmacy. By the end of the week, NPR's David Folkenflik summarized the situation and the larger conflict in how to
The revelations pointed toward a larger discussion over how to do the tough work of making local journalism sustainable, summarized well by NPR's David Folkenflik. Northeastern j-prof Dan Kennedy said operations like Journatic's "pink slime journalism" are a function of the fact that local journalism is difficult and expensive to do well, Cipro schedule, though the solution will ultimately come from the bottom up, not from cookie-cutter approaches like this. Free Press, meanwhile, urged us to demand better out of local news. Buy Cipro No Prescription, But others saw outsourced local journalism (though without fake bylines, of course) as a viable part of the future of news: Mathew Ingram also made the point that local journalism is expensive and said centralized and automated news production has to be part of the answer. John Bethune of B2B Memes said the real problem at Journatic was that it was skeuomorphic — trying to make a new form (algorithmic and outsourced content) look like an old one (articles with bylines). "The Journatic screw-up was not a failure of new media, Cipro steet value, but a failure of nerve. New-media practitioners need to have the courage of their convictions, and look, not back, Cipro samples, but steadfastly ahead." Ingram echoed that point, urging an open mind toward Journatic in a follow-up post, and Kennedy responded that "not everything new should be embraced."
Twitter tightens its grip: In a pair of simultaneous posts, Twitter broke off its content-syncing partnership with LinkedIn and served notice to other Twitter third-party developers that the company wouldn't be standing for apps that they feel closely mimic the "core Twitter consumption experience" on their own apps and website. All Things D's Mike Isaac said that it makes sense for Twitter to tighten the reins on its service now that it's growing and wondered how it might affect other partners such as Flipboard. Talking Points Memo's Carl Franzen asked the same thing about several companies whose services are based predominantly or exclusively on Twitter, Cipro from canada.
The Next Web's Matthew Panzarino talked to developers who called Twitter's post "ominous" and suggested the reason Twitter seems to be clamping down on its famously open development system is that it wants to control its advertising stream, Buy Cipro No Prescription. The New York Times' Nick Bilton, meanwhile, pointed out that the core user experience Twitter wants to protect isn't consistent at all between its website and various apps. BuzzFeed's Matt Buchanan said Twitter wants to make all those user experiences consistent, Purchase Cipro for sale, as well as simpler and more dynamic — and in order to do that, it needs total control of the experience.
GigaOM's Mathew Ingram issued a warning to Twitter, noting that it's upset its developer community before, and similar moves have backfired for MySpace and Digg. Tech entrepreneur Dalton Caldwell lamented the fact that Twitter hadn't chosen an API-centric route years ago, buy Cipro online cod, and Ingram explored the question of whether a media company such as Twitter could be both an open platform and a destination.
In another post Buy Cipro No Prescription, , Ingram looked at the feasibility of an open alternative to Twitter, concluding that it would be technically possible, but not likely to draw Twitter's critical mass of users. "In the end, many users don’t really seem to care whether a system or network is open or not — or at least not enough of them to make a difference," he wrote.
Another key piece of this puzzle came at about the same time, when the Wall Street Journal reported that Twitter is finding success selling ads for mobile devices, a platform that has frustrated Facebook and Google's advertising teams. Cipro online cod, The Financial Times likewise reported that Twitter has shifted to a truly mobile-first mindset, and Business Insider's Pascal-Emmanuel Gobry argued that that mobile-first nature, along with the fact that Twitter has the same ads on desktop and mobile, bodes well for Twitter's mobile business.
The future of News Corp.'s papers: We're continuing to see the repercussions from News Corp.'s decision two weeks ago to split into two separate news and entertainment media companies. The Wall Street Journal gave the details of the decision, buy Cipro from mexico, and David Carr of The New York Times explained why Rupert Murdoch had agreed to make the deal — his papers, with the exception of Dow Jones' Wall Street Journal, are declining quickly, and "his long-running romance with print will no longer be indulged just because he’s the boss."
The Times' Amy Chozick noted that the Murdochs are still firmly in control of the two companies (much to the annoyance of some investors), Where can i buy cheapest Cipro online, Peter Jukes of The Daily Beast said the split will hasten the end of the Murdoch dynasty. And though Murdoch praised the potential of his newspapers, The Times reported that without him directly heading the papers up, they're in a particularly vulnerable spot, Buy Cipro No Prescription. Forbes' Jeff Bercovici said the Journal will be well preserved as the company's crown jewel, but the outlook is much worse for the New York Post. The Daily Beast's Alex Klein expected the Journal to be remade in the image of its business news rival, Bloomberg.
Reuters' Felix Salmon focused on the TV side, buy Cipro without prescription, arguing that TV news is more part of the entertainment industry than the news industry, and that print media is converging on the one thing it does well — live breaking news coverage. Ad Age's Jeanine Poggi wondered whether other conglomerates like Time Warner will also spin off their print properties.
CNN's error and process journalism: Media observers also spent some time last week talking about CNN and Fox News' Supreme Court reporting error Buy Cipro No Prescription, , wondering why it happened and what that might mean about the state of news. Poynter's Steve Myers pinned the blame on "process journalism, Buy cheap Cipro no rx, " the philosophy of publishing stories as you piece them together and updating them with corrections. Myers said process journalism makes more sense in breaking news stories, not "appointment" stories like a Supreme Court decision. In a response, process journalism advocate Jeff Jarvis said this wasn't really process journalism, and "The real lesson here is that the scoop is and always has been a dangerous act of journalistic narcissism."
GigaOM's Mathew Ingram agreed with Jarvis on the diminishing value of the scoop and the idea that this wasn't process journalism, discount Cipro, and the Washington Post's Alexandra Petri also said this piece of news wasn't worth a scoop. Mike Masnick of Techdirt argued that this error shouldn't be cited as an indictment of the real-time news era. Poynter's Craig Silverman broke down the error in a bit more detail, attributing it in part to a "collision of complexity and immediacy."
Reading roundup: A few other stories and pieces to get to from the past holiday week:
— WikiLeaks began releasing its 2.4 million Syria-related emails last week, and while it initially named the AP as one of its collaborators, the AP was removed from the collaborator list and insisted it didn't collaborate with WikiLeaks, Buy Cipro No Prescription. The Atlantic's Alexander Abad-Santos questioned how everyone was going to sort through all the documents, and elsewhere, Buy Cipro no prescription, Agence France-Presse explored whether the U.S. has a case against WikiLeaks' Julian Assange.
— The Lab's Justin Ellis wrote an interesting piece looking at The New York Times' new Chinese-language site, but the project's already faced a setback, as its account on the Chinese Twitter-like site Sina Weibo has been shut down.
— Finally, a few cool articles worth reading this weekend: Here at the Lab, Ken Doctor wrote about aggregation apps like Pulse and the way metrics and subscription plans translate into money, and former GOOD magazine editor Ann Friedman offered some wise advice to young journalists and j-school grads. And tech blogger Erick Schonfeld argued that infographics are broken and proposed an alternative way of creating them.
Similar posts: Order Diflucan. Bactrim No Rx. Purchase Diflucan. Low dose Diflucan. Kjøpe Flagyl på nett, köpa Flagyl online. Bactrim treatment.
Trackbacks from: Buy Cipro No Prescription. Buy Cipro No Prescription. Buy Cipro No Prescription. Comprar en línea Cipro, comprar Cipro baratos. Cipro dangers. Cipro pictures.